TABLE 1.
Correlation between change in fatigue and demographics, disability, and quality of life
| Outcome measure | Baseline, mean (SD) | Month 12, mean (SD) | Mean change within subject (SD) | p | Spearman, rho (p) |
|---|---|---|---|---|---|
| FSS | 31.9 (16.4) | 32.8 (14.2) | 1.2 (16.2) | – | – |
| Presence of fatigue (FSS > = 36) (%) | 40.8 | 40.0 | |||
| Age at enrollment, years (SD) | 59.4 (14.0) | – | .77 | .06 (.67) | |
| Age disease onset, years (SD) | 54.5 (14.9) | – | .41 | −.14 (.32) | |
| Female, n (%) | 20 (40%) | – | .08 | – | |
| I‐RODS | 65.8 (24.3) | 61.1 (23.6) | −4.2 (7.8) | <.01 | −.41 (<.01) |
| INCAT | 1.67 (1.95) | 2.1 (1.9) | 0.6 (1.6) | .14 | .10 (.49) |
| CAP‐PRI | 9.7 (8.1) | 13.4 (7.9) | 1.1 (6.1) | <.01 | −.66 (<.01) |
| CDAS 1, 2 (off immunotherapy), n (%) | 26 (52%) | 34 (68%) | 8 (2%) | .92 | – |
| PGIC perceived change in health over 1 year | 2.9 (1.2) | 3.1 (1.0) | 0.2 (1.0) | .02 | .43 (<.01) |
| PGIC perception of health | 3.0 (1.0) | 3.2 (1.1) | 0.2 (1.1) | <.01 | .52 (<.01) |